Up and away with cervical cancer: IL-29 is a promising cytokine for immunotherapy of cervical cancer due to its powerful upregulation of p18, p27, and TRAILR1-Reference-Cited by-同舟云学术

Up and away with cervical cancer: IL-29 is a promising cytokine for immunotherapy of cervical cancer due to its powerful upregulation of p18, p27, and TRAILR1

Published:2024-01-28 Issue:3 Volume:41 Page:
ISSN:1559-131X
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Ha Jackie L.,Kaser Erin,Guan Tianyun,Mayberry Trenton G.,Smith Luke A.,D’mello Kyle,Bai Qian,Wakefield Mark R.,Dong Lijun,Fang Yujiang^ORCID

Funder

Des Moines University

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12032-023-02276-3.pdf

Reference40 articles.

1. Olusola P, Banerjee HN, Philley JV, Dasgupta S. Human papilloma virus-associated cervical cancer and health disparities. Cells. 2019;8(6):622. https://doi.org/10.3390/cells8060622.

2. Ferrall L, Lin KY, Roden RBS, Hung CF, Wu TC. Cervical cancer immunotherapy: facts and hopes. Clin Cancer Res. 2021;27(18):4953–73. https://doi.org/10.1158/1078-0432.CCR-20-2833.

3. Turinetto M, Valsecchi AA, Tuninetti V, Scotto G, Borella F, Valabrega G. Immunotherapy for cervical cancer: are we ready for prime time? Int J Mol Sci. 2022;23(7):3559. https://doi.org/10.3390/ijms23073559.

4. Monk BJ, Enomoto T, Kast WM, et al. Integration of immunotherapy into treatment of cervical cancer: Recent data and ongoing trials. Cancer Treat Rev. 2022;106:102385. https://doi.org/10.1016/j.ctrv.2022.102385.

5. Wendel Naumann R, Leath CA 3rd. Advances in immunotherapy for cervical cancer. Curr Opin Oncol. 2020;32(5):481–7. https://doi.org/10.1097/CCO.0000000000000663.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress in Induced Pluripotent Stem Cell Neoplasia;Advances in Clinical Medicine;2024